Tiotropium Handihaler vs. Tiotropium Respimat in COPD - Trial NCT05838703
Access comprehensive clinical trial information for NCT05838703 through Pure Global AI's free database. This Phase 2 trial is sponsored by Duke University and is currently Withdrawn. The study focuses on Chronic Obstructive Pulmonary Disease (COPD). Target enrollment is 0 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
tiotropium bromide inhalation powder (Spiriva HandiHaler)
Interventional
drug
Sponsor & Location
Duke University
Timeline & Enrollment
Phase 2
May 01, 2023
May 01, 2024
Primary Outcome
Assess the change in ventilation distribution parameters by 129Xe MRI in patient while taking Spiriva HandiHaler,Assess the change in ventilation distribution parameters by 129Xe MRI in patient while taking patient while taking Spiriva Respimat,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva HandiHaler,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva HandiHaler,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva HandiHaler,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva HandiHaler,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva Respimat,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva Respimat,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva Respimat,Assess the changes in Pre- and Post-Spirometry procedure while on Spiriva Respimat
Summary
The purpose of this study is to determine if tiotropium Respimat will result in better
 ventilation distribution of the lung in COPD participants quantified by hyperpolarized XeMRI.
 This study is designed to simulate the real-life clinical setting where patients receive
 one-time instruction on the inhaler use.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05838703
Non-Device Trial